North America continues to play a significant role in the growth of the Diphtheria Toxoid market due to its well-established healthcare infrastructure, widespread vaccination programs, and strong focus on disease prevention. The region's commitment to maintaining high immunization coverage rates has supported the demand for diphtheria toxoid-containing vaccines. Additionally, ongoing...